Literature DB >> 7002342

Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.

R I Glazer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7002342     DOI： 10.1007/bf00255266

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  87 in total

1.  Role of nonhistone chromosomal proteins in the regulation of histone gene expression.

Authors:  G S Stein; J L Stein; L J Kleinsmith; J A Thomson; W D Park; R L Jansing
Journal:  Cancer Res       Date:  1976-11       Impact factor: 12.701

2.  Studies of the relationship between adenosine deaminase and immune function.

Authors:  P W Burridge; V Paetkau; J F Henderson
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

3.  Effects of 2'-deoxycoformycin, 9-beta-D-arabinofuranosyladenine 5'-phosphate, and 1-beta-D-arabinofuranosylcytosine triple combination therapy on intracerebral leukemia 1210.

Authors:  N Caron; S H Lee; A P Kimball
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

4.  Treatment of acute lymphoblastic leukemia with 2'-deoxycoformycin: clinical and biochemical consequences of adenosine deaminase inhibition.

Authors:  C A Koller; B S Mitchell; M R Grever; E Mejias; L Malspeis; E N Metz
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

5.  Structure of coformycin, an unusual nucleoside of microbial origin.

Authors:  H Nakamura; G Koyama; Y Iitaka; M Ono; N Yagiawa
Journal:  J Am Chem Soc       Date:  1974-06-26       Impact factor: 15.419

6.  Effects of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nornyl)adenine on plasma levels and urinary excretion of 9-beta-D-arabinofuranosyladenine in the mouse 1,2,3.

Authors:  W J Suling; L S Rice; W M Shannon
Journal:  Cancer Treat Rep       Date:  1978-03

7.  Potentiation by 2'-deoxycoformycin of the inhibitory effect of xylosyladenine on nuclear RNA synthesis in L1210 cells in vitro.

Authors:  A L Peale; R I Glazer
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

8.  Biochemical basis of the increased activity of 9-beta-D-arabinofuranosyladenine in the presence of inhibitors of adenosine deaminase.

Authors:  W Plunkett; L Alexander; S Chubb; T L Loo
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

9.  Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis.

Authors:  D A Carson; J E Seegmiller
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

10.  Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2'-deoxycoformycin.

Authors:  R H Adamson; D W Zaharevitz; D G Johns
Journal:  Pharmacology       Date:  1977       Impact factor: 2.547
View more
  9 in total

1.  Contrasting behavior of conformationally locked carbocyclic nucleosides of adenosine and cytidine as substrates for deaminases.

Authors:  Victor E Marquez; Gottfried K Schroeder; Olaf R Ludek; Maqbool A Siddiqui; Abdallah Ezzitouni; Richard Wolfenden
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-05       Impact factor: 1.381

Review 2.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

3.  Metabolic and functional consequences of inhibiting adenosine deaminase during renal ischemia in rats.

Authors:  M E Stromski; A van Waarde; M J Avison; G Thulin; K M Gaudio; M Kashgarian; R G Shulman; N J Siegel
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

4.  Enzymatic interconversion of isomorphic fluorescent nucleosides: adenosine deaminase transforms an adenosine analogue into an inosine analogue.

Authors:  Renatus W Sinkeldam; Lisa S McCoy; Dongwon Shin; Yitzhak Tor
Journal:  Angew Chem Int Ed Engl       Date:  2013-11-29       Impact factor: 15.336

5.  Transition-state variation in human, bovine, and Plasmodium falciparum adenosine deaminases.

Authors:  Minkui Luo; Vipender Singh; Erika A Taylor; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2007-05-31       Impact factor: 15.419

6.  Identification of a New Uncompetitive Inhibitor of Adenosine Deaminase from Endophyte Aspergillus niger sp.

Authors:  Xin-Guo Zhang; Jin-Wen Liu; Peng Tang; Zi-Yu Liu; Guang-Jun Guo; Qiao-Yun Sun; Jian-Jun Yin
Journal:  Curr Microbiol       Date:  2017-12-14       Impact factor: 2.188

7.  Effects of aqueous extract from Silybum marianum on adenosine deaminase activity in cancerous and noncancerous human gastric and colon tissues.

Authors:  Bahadır Öztürk; Ender Hilmi Kocaoğlu; Zahide Esra Durak
Journal:  Pharmacogn Mag       Date:  2015 Jan-Mar       Impact factor: 1.085

8.  A new strategy based on pharmacophore-based virtual screening in adenosine deaminase inhibitors detection and in-vitro study.

Authors:  Roya Bazl; Mohammad Reza Ganjali; Ali-Akbar Saboury; Alireza Foroumadi; Parviz Nourozi; Massoud Amanlou
Journal:  Daru       Date:  2012-10-22       Impact factor: 3.117

9.  Aqueous extract from taxus baccata inhibits adenosine deaminase activity significantly in cancerous and noncancerous human gastric and colon tissues.

Authors:  Zahide Esra Durak; Süleyman Büber; Erdinç Devrim; Hilmi Kocaoğlu; Ilker Durak
Journal:  Pharmacogn Mag       Date:  2014-04       Impact factor: 1.085
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.